ARYx Therapeutics, Inc. Stock
Stocks
ARYX
US0433871094
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000001 USD | -.--% |
|
-.--% | - |
| Market Cap | 9.03M 7.85M 7.31M 6.71M 12.67M 862M 12.87M 86.17M 33.82M 429M 33.93M 33.19M 1.44B | P/E 2008 |
-1.76x | P/E 2009 | -2.66x |
|---|---|---|---|---|---|
| Enterprise Value | 11.41M 9.92M 9.23M 8.47M 16M 1.09B 16.25M 109M 42.69M 542M 42.84M 41.89M 1.82B | EV / Sales 2008 |
4,019,605x | EV / Sales 2009 | - |
| Free-Float |
100% | Yield 2008 * |
-
| Yield 2009 | - |
| 5 years | 0 |  | 0.04 |
| 10 years | 0 | | 0.05 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 33 | |
| +2.35% | +2.74% | +33.41% | +79.20% | 56.54B | |
| -0.21% | -7.38% | +25.34% | +63.02% | 53.6B | |
| -2.44% | +1.40% | -15.74% | -16.80% | 22.91B | |
| -2.85% | -7.78% | -8.09% | +346.36% | 21.37B | |
| +2.49% | -0.92% | +20.31% | -12.15% | 20.27B | |
| +0.79% | -1.06% | +29.29% | -33.32% | 17.56B | |
| +0.58% | -5.88% | +16.30% | +540.37% | 14.75B | |
| -5.25% | -4.23% | +46.41% | +169.05% | 13.33B | |
| +3.41% | -6.61% | +163.08% | +280.43% | 13.53B | |
| Average | -0.11% | -3.41% | +34.48% | +157.35% | 23.39B | |
| Weighted average by Cap. | +0.23% | -2.96% | +28.67% | +119.98% |
| 2008 | 2009 | |
|---|---|---|
| Net sales | 19.72 17.15 15.96 14.65 27.67 1.88K 28.1 188.12 73.83 937.37 74.08 72.45 3.14K | - |
| Net income | -31.22M -27.14M -25.26M -23.19M -43.79M -2.98B -44.47M -298M -117M -1.48B -117M -115M -4.97B | -33.17M -28.83M -26.84M -24.64M -46.53M -3.17B -47.25M -316M -124M -1.58B -125M -122M -5.29B |
| Net Debt | -29.9 -26 -24.2 -22.22 -41.95 -2.85K -42.6 -285.22 -111.94 -1.42K -112.31 -109.84 -4.77K | 2.37 2.06 1.92 1.76 3.33 226.34 3.38 22.61 8.88 112.68 8.9 8.71 377.84 |
Employees
56
- Stock Market
- Stocks
- ARYX Stock
Select your edition
All financial news and data tailored to specific country editions
